Effect of Myocilin Genetic Variants on Intraocular Pressure and Pressure Variation in Sitting and Supine Positions
Status:
Completed
Trial end date:
2012-07-18
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if one of the genes that can cause glaucoma, called
myocilin, are associated with larger eye pressure and blood pressure changes in sitting and
lying down positions without glaucoma drug treatment and with glaucoma drug treatment with a
combination medication called Cosopt® (Merck & Co., Inc.).